The INDICAID Rapid Antigen Test is a FDA Authorized and CE-marked lateral flow immunoassay designed for the qualitative detection of SARS-CoV-2 antigens in direct nasal swab samples.
Clinically validated with overall sensitivity and specificity at 96% and 99% respectively, INDICAID provides intuitive visual results in 20 minutes. No special equipment or facilities needed.
INDICAID is designed for primary screening only. If you have any doubts about the test results, seek medical advise immediately. The Test result should be used in conjunction with other clinical information to diagnose COVID-19 infection. If you are suspecting an infection, feeling unwell or have any symptoms such as fever, cough, runny nose, sore throat, you should consult medical professionals immediately for the confirmation of diagnosis.
• The test must be performed between 18-25°C
• Store at 2-30°C. Do not freeze
• Avoid direct sunlight
• Do not swallow or inhale
- Up to 96% Sensitivity
- Early Detection
- Results in 20 min
- FDA Authorized
- Nasal Swab
- Easy to Use
|Type||Lateral Flow Detection (LFD) In-vitro Qualitative Detection|
|Reusable||No (Single-Time Use)|
|Result Time||20 minutes|
|Detection||SARS-CoV-2 Virus Antigen|
|Certifications||FDA Authorized (Emergency Use), CE|
|Manufacturer||Phase Scientific International|